Mounjaro 5Mg Kwikpen

Overview of Mounjaro 5mg KwikPen

Mounjaro 5 mg KwikPen (active ingredient: Tirzepatide) is a once-weekly subcutaneous injection formulated for adult use in the management of type 2 diabetes mellitus and overweight/obesity (in conjunction with diet and exercise). It combines dual hormone-action (GIP and GLP-1 receptor agonism) to improve glycemic control and support weight reduction. The 5 mg strength is part of a multi-dose pen design (KwikPen) containing four fixed weekly doses, designed for convenience in long-term use and personalised dosing escalation. 

Mechanism of Action for Type 2 Diabetes & Weight Management

Mounjaro 5mg KwikPen works through its active ingredient, Tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. This dual mechanism enhances insulin secretion, reduces glucagon levels, and slows gastric emptying,...